Opioid Safety: Balancing Benefits and Risks _ _____________________________________________________
19. Extended-release/long-acting (ER/LA) opioids should be reserved for A) severe, acute pain.
25. For pregnant people with opioid use disorder, which pharmacotherapy is recommended? A) Fentanyl
B) moderate, chronic pain. C) severe, continuous pain. D) acute pain at the end of life.
B) Bupropion C) Naltrexone D) Buprenorphine or methadone
20. In which case might opioid therapy be discontinued abruptly? A) Pregnancy B) Constipation
26. Which of the following behaviors is the most suggestive of an emerging opioid use disorder? A) Asking for specific medications B) Injecting medications meant for oral use C) Reluctance to decrease opioid dosing once stable
C) Signs of impending overdose D) Desire to discontinue therapy
D) Stockpiling medications during times when pain is less severe
21. Following initiation of opioid therapy for subacute or chronic pain or dose escalation, clinicians should evaluate benefits and risks with patients A) within one to four weeks. B) after one month. C) every three months. D) annually. 22. Clinicians should offer naloxone when prescribing opioids to patients at increased risk for overdose. Which of the following patients would be considered at increased risk for overdose?
27. Which government agency is responsible for formulating federal standards for the handling of
controlled substances? A) Institutes of Medicine
B) U.S. Drug Enforcement Administration C) Office of National Drug Control Policy D) U.S. Department of Health and Human Services
28. All of the following should be included in the education of patients prescribed opioids, EXCEPT: A) Product-specific concerns B) Risk of serious adverse events that can lead to death C) Instructions for safe sharing of opioids with others D) How to safely taper dose to avoid withdrawal symptoms 29. Which of the following statements regarding the disposal of opioids is TRUE? A) Patients are almost always advised of what to do with unused or expired medications. B) There are no universal recommendations for the proper disposal of unused opioids. C) According to the FDA, most medications should be flushed down the toilet instead of thrown in the trash. D) All of the above
A) A patient older than 65 years of age B) A patient with obstructive sleep apnea C) A patient taking lower dosages of opioids D) A patient who is also taking an antidepressant
23. Which of the following statements regarding toxicology testing is NOT in accordance with CDC guidance? A) Clinicians should dismiss patients from care based on a toxicology test result. B) Clinicians should use unexpected toxicology test results to improve patient safety. C) Clinicians who believe their patient might be diverting prescription opioids should consider toxicology testing to assist in determining whether prescription opioids can be discontinued without causing withdrawal. D) When prescribing opioids for subacute or chronic pain, clinicians should consider toxicology testing to assess for prescribed medications as well as other prescribed and non-prescribed controlled substances. 24. Risks of concurrent opioid and benzodiazepine use are likely to be greater with A) unpredictable use of either medication.
30. Implicit biases can impact opioid prescribing
practices. Which of the following strategies can promote positive emotions and help reduce implicit biases? A) The use of interpreters B) Frequent career changes C) Perspective taking and role playing D) Increased opioid prescribing for racial/ethnic minority patients
B) use with other substances including alcohol. C) use of higher-dose opioids and higher-dose benzodiazepines in combination. D) All of the above
Course Code: MDPA05OS
51
MDPA2126
Powered by FlippingBook